Everspin Technologies, Inc.
10.85+0.36 (+3.43%)
Oct 29, 4:00:02 PM EDT · NasdaqGM · MRAM · USD
Key Stats
Market Cap
245.48MP/E (TTM)
120.56Basic EPS (TTM)
0.09Dividend Yield
0%Recent Filings
10-Q
Q2 FY2025 results
Everspin Technologies posted solid Q2 revenue of $13.2M, up 24.1% y/y from $10.6M, fueled by 12.2% higher product sales and a 181.7% surge in licensing revenue from RAD-Hard and AI projects, while YTD revenue edged up 5.1% to $26.3M. Gross margin expanded to 51.3% from 49.0% y/y, thanks to favorable product mix, yet operating loss narrowed to $2.0M from $2.8M as expenses rose modestly. Diluted EPS improved to $(0.03) from $(0.12), aligning with 22.5M weighted shares and no dilution. Cash climbed to $45.0M with $6.5M operating cash flow, minus $2.9M capex for free cash flow of $3.6M (derived); no debt burdens the balance sheet. Strategic award income of $0.9M bolstered results. Competition from larger memory players remains a key risk.
8-K
Everspin Q2 revenue surges 24%
Everspin Technologies reported Q2 2025 revenue of $13.2 million, up 24% from $10.6 million a year ago, fueled by $11.1 million in MRAM sales and $2.1 million in licensing revenue, while gross margin climbed to 51.3%. The company swung to a GAAP net loss of $0.7 million but posted non-GAAP net income of $0.7 million, with cash reserves hitting $45.0 million. It bolstered its executive team with new sales and business development VPs to speed revenue growth. Q3 outlook targets $13.5–14.5 million in revenue. Supply chain volatility lingers as a risk.
8-K
Everspin's annual meeting results
Everspin Technologies held its 2025 Annual Meeting on May 22, where all seven director nominees were elected despite some withheld votes, Ernst & Young LLP's appointment as auditors was ratified with strong support, and the say-on-pay proposal passed handily. Votes for directors ranged from 7.9 million to 10.2 million for, while auditor ratification drew 15.2 million yes votes against 1.1 million no. Shareholder alignment shines through. No major red flags emerged.
8-K
Everspin Q1 revenue dips slightly
Everspin Technologies reported Q1 2025 revenue of $13.1 million, down 9% from $14.4 million last year, with MRAM product sales steady at $11.0 million while licensing revenue fell to $2.1 million. Gross margin slipped to 51.4% amid higher costs, yielding a GAAP net loss of $1.2 million, yet non-GAAP net income held at $0.4 million. New Orion xSPI products target aerospace and defense, bolstering design wins. Cash grew to $42.2 million. Q2 revenue eyes $12.5-13.5 million, but tariffs loom as a fluid risk.
10-Q
Q1 FY2025 results
Everspin Technologies posted Q1 FY2025 revenue of $13.1M, down 9.0% y/y from $14.4M, as licensing and royalty revenue dropped 40.8% to $2.1M amid project progressions, while product sales edged up 1.5% y/y to $11.0M. Gross margin slipped to 51.4% from 56.5%, reflecting product mix shifts and lower fab loadings, yet operating expenses held steady at $8.7M, trimming the operating loss to $1.9M from $0.6M. Diluted EPS landed at $(0.05), aligning with 22.2M weighted shares and no anti-dilution effects. Cash stayed flat at $42.2M, with operating cash flow at $1.4M and free cash flow of $0.5M (derived), bolstered by a $14.6M strategic award for aerospace supply chain work. No debt burdens the balance sheet. Tariffs and trade barriers pose risks to costs and demand.
AMKR
Amkor Technology, Inc.
32.69+0.53
GSIT
GSI Technology, Inc.
11.60+0.17
MCHP
Microchip Technology Incorporat
62.54-1.10
MMTIF
Micromem Technologies, Inc.
0.03+0.00
MRVL
Marvell Technology, Inc.
90.15+1.69
MU
Micron Technology, Inc.
226.63+4.72
NMTC
NeuroOne Medical Technologies C
0.79-0.03
NVEC
NVE Corporation
72.00-0.31
RMBS
Rambus, Inc.
111.36+7.64
UMC
United Microelectronics Corpora
7.39-0.24